226 related items for PubMed ID: 18218301
41. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
[Abstract] [Full Text] [Related]
42. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K, El-Reshaid W, Madda J.
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[Abstract] [Full Text] [Related]
43. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
44. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
45. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[Abstract] [Full Text] [Related]
46. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F, Ahmad TM, Anwar S.
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[Abstract] [Full Text] [Related]
47. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[Abstract] [Full Text] [Related]
48. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Apr; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
49. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome.
Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M, Japanese Study Group of Renal Disease.
Pediatr Nephrol; 2009 Nov; 24(11):2177-85. PubMed ID: 19714370
[Abstract] [Full Text] [Related]
50. [Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children].
Rao J, Xu H, Cao Q, Huang WY, Zhou LJ.
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):958-63. PubMed ID: 18182710
[Abstract] [Full Text] [Related]
51. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M, Ishihara M, Morita T, Hayashi A, Utsunomiya Y, Ohta T, Sakano T, Wakiguchi H.
Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
[Abstract] [Full Text] [Related]
52. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
Shatat IF, Schoeneman M, Flynn JT, Woroniecki RP.
Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224
[Abstract] [Full Text] [Related]
53. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S, Imai N, Sueki S, Matsui K, Tominaga N, Sakurada T, Yasuda T, Kimura K, Shibagaki Y.
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[Abstract] [Full Text] [Related]
54. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
55. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A.
Pediatr Nephrol; 2012 Nov; 27(11):2073-2079. PubMed ID: 22714672
[Abstract] [Full Text] [Related]
56. Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome.
Hymes LC.
Pediatr Nephrol; 1995 Apr; 9(2):137-9. PubMed ID: 7794704
[Abstract] [Full Text] [Related]
57. Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis.
El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmed N, Sobh M.
Am J Nephrol; 2004 Apr; 24(3):301-6. PubMed ID: 15133323
[Abstract] [Full Text] [Related]
58. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
Pediatr Nephrol; 2015 Apr; 30(4):687-91. PubMed ID: 25576066
[Abstract] [Full Text] [Related]
59. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.
Sümegi V, Haszon I, Bereczki C, Papp F, Túri S.
Pediatr Nephrol; 2008 Jul; 23(7):1085-92. PubMed ID: 18324421
[Abstract] [Full Text] [Related]
60. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Salomon R, Gagnadoux MF, Niaudet P.
Transplantation; 2003 Mar 27; 75(6):810-4. PubMed ID: 12660507
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
